Yüklüyor......
Adverse Effects of GLP-1 Receptor Agonists
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of injective anti-diabetic drugs that improve glycemic control and many other atherosclerosis-related parameters in patients with type 2 diabetes (T2D). However, the use of this relatively new class of drugs may be associated with certain...
Kaydedildi:
| Yayımlandı: | Rev Diabet Stud |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SBDR - Society for Biomedical Diabetes Research
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5397288/ https://ncbi.nlm.nih.gov/pubmed/26177483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2014.11.202 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|